Abstract: Provided are a conjugate including a core and sialic acids or derivatives thereof bound to the surface of the core, and use thereof. The conjugate provided in the present invention binds with hemagglutinin on the surface of influenza virus to inhibit the course of infection of influenza virus, thereby preventing or treating infection of influenza virus and also preventing or treating infection of influenza virus resistant to antiviral agents. Accordingly, the conjugate may be widely used in the development of prophylactic or therapeutic agents for influenza virus infection.
Type:
Grant
Filed:
August 17, 2017
Date of Patent:
January 5, 2021
Assignees:
Kabio R&D SOO Co., Ltd., Rensselaer Polytechnic Institute
Inventors:
Jong Hwan Kwak, Seok-Joon Kwon, Robert J. Linhardt, Jonathan S. Dordick, Fuming Zhang